SCHEMBL208948

SCHEMBL208948

COC(=O)c1ccc(-c2cc(Cl)c(C[C@@H]3CCN([C@H]4CC[C@H](OC)CC4)C3=O)c(Cl)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.37
TSHR P16473 2/20 0.37
KDM4E B2RXH2 2/20 0.36
ATM Q13315 2/20 0.36
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
HSD17B10 Q99714 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
CHKA P35790 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CHRM4 P08173 1/20 0.35
HSD11B1 P28845 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL208947 1.00 ALDH1A1 (0.37) ALDH1A1TSHRKDM4EATMGAA
SCHEMBL208451 0.91 HSD11B1 (0.37) TSHRHSD11B1PDE4APDE4BPDE4C
SCHEMBL208450 0.91 HSD11B1 (0.37) TSHRHSD11B1PDE4APDE4BPDE4C
SCHEMBL208480 0.90 HSD11B1 (0.45) ALDH1A1TSHRATMHPGDCHKA
SCHEMBL210504 0.89 ALDH1A1 (0.41) ALDH1A1KDM4EHPGDHSD17B10CHKA
SCHEMBL207568 0.89 SLC6A4 (0.34) ALDH1A1TSHRKDM4EATMGAA
SCHEMBL207569 0.89 SLC6A4 (0.34) ALDH1A1TSHRKDM4EATMGAA
SCHEMBL209005 0.89 SLC6A4 (0.34) ALDH1A1TSHRKDM4EATMGAA
SCHEMBL474903 0.87 CMA1 (0.35) ALDH1A1TSHRKDM4EATMHSD17B10
SCHEMBL209475 0.85 PARP1 (0.43) HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2016047-B1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11- BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2013-08-28 EP disclosed
US-8088776-B2 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2012-01-03 US disclosed
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD17B1, HSD11B2 ALDH1A1 88/4885TSHR 3508/4885KDM4E 1143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.